Prior close: $35.50
A great Q1 thanks to COVID-19
The global pathology services provider Sonic Healthcare (ASX:SHL) released a trading update yesterday with its September quarter results.
During the first quarter of the 2021 financial year, SHL’s revenues grew 29% to $2.14 billion and EBITDA increased 71% to $580 million. That is a very strong start to the year, considering the market was only forecasting 13% revenue growth and 15% EBITDA growth for the full year.